Status:
WITHDRAWN
Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT Angiography
Lead Sponsor:
Stanford University
Conditions:
Acute Kidney Injury
Renal Insufficiency, Chronic
Eligibility:
All Genders
21-75 years
Brief Summary
This study evaluates the safety of iodinated contrast medium administered to liver transplant candidates with decreased renal function undergoing coronary CT angiography. Incidence of post-contrast ac...
Detailed Description
Low osmolar non-ionic contrast medium (LOCM) is routinely used for contrast-enhanced computed tomography (CT) including coronary computed tomography angiography (CCTA). This study evaluates the effec...
Eligibility Criteria
Inclusion
- \- Liver transplant candidate, age \> 21 referred for coronary CT angiography, medium-risk patient for coronary artery disease
Exclusion
- Liver transplant candidates who are at low-risk for coronary artery disease and therefore do not need coronary CT angiography or invasive catheterization
- Liver transplant candidates who are at high-risk for coronary artery disease and are referred directly to invasive catheterization
- Candidates with chronic kidney disease stage 4, with eGFR \<30 ml/min/1.73m2
- Known or suspected allergy to standard iodine contrast medium
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03806725
Start Date
June 1 2020
End Date
March 30 2022
Last Update
January 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanfor University
Stanford, California, United States, 94305